AGP Picks
View all

Harrisburg Wellness Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.

Press releases published on October 12, 2026

Acclaim Autism Named to the 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
CMTA Honors World-Renowned Clinician Michael E. Shy, MD, with Lifetime Achievement Award
Premiere Dental Adds Digital X-Rays, iTero Scanner and CBCT 3D Imaging
Arkview Behavioral Health of Fayetteville Opens as a Purpose-Built Residential Mental Health Facility
20/15 Visioneers and StableBody Technologies Partner on Expression-Risk Screening for Industrial Enzymes
Shamrock Medicine Adds Board-Certified Physician Assistant William Brewer at Philadelphia and Chestnut Hill Locations
NexLife Announces October 2026 GLP-1 Price Index on Online Prices of Compounded Tirzepatide and Semaglutide
Teva to Host R&D Day on Wednesday, November 11 in New York City
LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
Broken Tooth in West Hollywood? Same-Day Extraction and Implant Placement May Be an Option for Qualifying Patients
TeleSpecialists Reaches 2 Million Patient Encounters, Achieving Second Million in Less Than One-Third the Time
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Harrisburg Wellness Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.